Diabetes and macrovascular disease

This publication has 76 references indexed in Scilit:

• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.
  The American Journal of Cardiology, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
  Archives of internal medicine (1960), 1997
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Interactions Between Endothelial Mediators
  Basic & Clinical Pharmacology & Toxicology, 1995
• Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus
  New England Journal of Medicine, 1990
• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989
• Diabetic Macroangiopathy
  Acta Medica Scandinavica, 1984